Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2014 May 15:14:219.
doi: 10.1186/1472-6963-14-219.

Effects of a TELephone Counselling Intervention by Pharmacist (TelCIP) on medication adherence, patient beliefs and satisfaction with information for patients starting treatment: study protocol for a cluster randomized controlled trial

Marcel J Kooy  1 , Erica C G van Geffen, Eibert R Heerdink, Liset van Dijk, Marcel L Bouvy
Affiliations
Randomized Controlled Trial

Effects of a TELephone Counselling Intervention by Pharmacist (TelCIP) on medication adherence, patient beliefs and satisfaction with information for patients starting treatment: study protocol for a cluster randomized controlled trial

Marcel J Kooy et al. BMC Health Serv Res. .

Abstract

Background: Adherence to medication is often low. Pharmacists may improve adherence, but a one-size-fits-all approach will not work: different patients have different needs. Goal of the current study is to assess the effectiveness of a patient-tailored, telephone-based intervention by a pharmacist at the start of pharmacotherapy aimed at improving medication adherence, satisfaction with information and counselling and the beliefs about medicines.

Methods/design: A cluster randomized controlled intervention trial in 30 Dutch pharmacies, randomly assigned to 1 of 2 intervention groups. Each group consists of an intervention arm and an usual care arm. The intervention arm in the first group is the usual care arm in the second group and vice versa. One intervention arm focuses on patients starting with antidepressants or bisphosphonates and the other on antilipaemic drugs or renin angiotensin system (RAS)-inhibitors. The intervention consists of a telephone call by a pharmacist 2 or 3 weeks after a new prescription. A random sample of pharmacies will send questionnaires 3 months after the first prescription. This contains socio-demographic questions, a measure of beliefs about medicines (BMQ), satisfaction with information received (SIMS, abbreviated) and frequency of pharmacy counselling (Consumer Quality Index, CQI, abbreviated). The primary outcome measure will be medication adherence calculated from dispensing records retrieved 12 months after the intervention. Patients' beliefs on medication, perception of the quality of information received and pharmacy counselling are secondary outcomes.

Discussion: The TelCIP study will determine the effectiveness of telephone counselling to improve adherence in patients initiating a new treatment. By measuring satisfaction with information and counselling and beliefs about medication the study will also give clues for the reason of a potential increase in adherence. Finally the study will provide information on which patients are most likely to benefit from this intervention.

Trial registration: The trial is registered at http://www.trialregister.nl under the identifier NTR3237.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Study design. Pharmacies are randomized in two groups. Each group consists of an intervention (TelCIP) arm and a usual care arm. The TelCIP arm in group A focuses on the same medication as the usual care arm in group B and vice versa.
Figure 2
Figure 2
Timeline per patient.
See this image and copyright information in PMC

References

    1. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;14(5):487–497. doi: 10.1056/NEJMra050100. - DOI - PubMed
    1. van Geffen EC, Gardarsdottir H, van Hulten R, van Dijk L, Egberts AC, Heerdink ER. Initiation of antidepressant therapy: do patients follow the GP’s prescription? Br J Gen Pract. 2009;14(559):81–87. doi: 10.3399/bjgp09X395067. - DOI - PMC - PubMed
    1. WHO. ADHERENCE TO LONG-TERM THERAPIES Evidence for action. 2003. - PubMed
    1. Phatak HM, Thomas J 3rd. Relationships between beliefs about medications and nonadherence to prescribed chronic medications. Ann Pharmacother. 2006;14(10):1737–1742. doi: 10.1345/aph.1H153. - DOI - PubMed
    1. van Geffen EC, Kruijtbosch M, Egberts AC, Heerdink ER, van Hulten R. Patients’ perceptions of information received at the start of selective serotonin-reuptake inhibitor treatment: implications for community pharmacy. Ann Pharmacother. 2009;14(4):642–649. doi: 10.1345/aph.1L393. - DOI - PubMed

Publication types

Associated data